Paladin Labs Inc.

Paladin Labs Inc.

April 02, 2007 08:00 ET

Paladin Wins Two Genesis Awards for Entrepreneurship

MONTREAL, QUEBEC--(CCNMatthews - April 2, 2007) - Paladin Labs Inc. (TSX:PLB), a leading Canadian specialty pharmaceutical company, proudly announces that the Company has won two Genesis awards. Paladin won the Biotechnology/Biopharmaceutical Entrepreneurship Award for outstanding growth and Jonathan Ross Goodman, President & CEO, won the BRIO Award for significant contribution to the development of the life sciences industry.

"We are proud of all of the hard work and effort that has gone into creating and upholding our vision. Our success could not have been achieved without the dedication of the entire Paladin team, and we look forward to continued success in the years ahead", said Jonathan Ross Goodman, President and CEO.

Started by BIOQuebec in 2001, the Genesis Award seeks to recognize Entrepreneurship, Innovation and Technology Transfer of companies and to honour individual pre-eminence among the personalities who have played a key role in the growth of Quebec's Life Sciences Industry.

About Paladin Labs

Paladin Labs Inc., headquartered in Montreal, Canada, is a specialty pharmaceutical company focused on acquiring or in-licensing innovative pharmaceutical products for the Canadian market. With this strategy, a focused national sales team and proven marketing expertise, Paladin has evolved into one of Canada's leading specialty pharmaceutical companies. Paladin's shares trade on the Toronto Stock Exchange under the symbol PLB. For more information about Paladin, please visit the Company's web site at

These forward-looking statements, by their nature, necessarily involve risks and uncertainties that could cause actual results to differ materially from those contemplated by the forward-looking statements. The Company considers the assumptions on which these forward-looking statements are based to be reasonable at the time they were prepared, but cautions that these assumptions regarding the future events, many of which are beyond the control of the Company and its subsidiary may ultimately prove to be incorrect. Factors and risks, which could cause actual results to differ materially from current expectations, are discussed in the annual report as well as in the Company's Annual Information Form for the year ended December 31, 2006. The Company disclaims any intention or obligation to update or revise any forward-looking statements whether a result of new information, future events, or except as required by law. For additional information on risks and uncertainties relating to these forward-looking statements, investors should consult the Company's ongoing quarterly fillings, annual report and Annual Information Form and other fillings found on SEDAR at

Contact Information